Iakovlev V P, Blatun L A, Terekhova R P
Antibiot Khimioter. 2005;50(2-3):48-51.
Clinical and microbiological efficacies of a combined drug, a fixed combination of ciprofloxacin and tinidazole in the form of tablets (Cifran ST, Ranbaxy, India) were studied. The drug was given to 40 patients with skin and soft tissue infections in the complex surgical treatment. The clinical effect and bacteriological efficacy were observed in 97.5 and 75% of the cases respectively. The drug tolerability was good and no adverse reactions were stated.
对一种复方药物(印度兰伯西公司生产的环丙沙星和替硝唑固定剂量组合片剂Cifran ST)的临床和微生物学疗效进行了研究。在复杂外科治疗中,将该药物给予40例皮肤和软组织感染患者。分别在97.5%和75%的病例中观察到临床效果和细菌学疗效。该药物耐受性良好,未报告不良反应。